Ken Griffin Sonoma Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.14 - $0.26 $27,321 - $50,740
195,157 New
195,157 $40,000
Q4 2023

Feb 14, 2024
BUY
$0.14 - $0.77 $16,349 - $89,919
116,779 New
116,779 $21,000
Q3 2022

Nov 14, 2022
SELL
$2.18 - $43.4 $15,931 - $317,167
-7,308 Reduced 28.46%
18,369 $39,000

Others Institutions Holding SNOA

# of Institutions
1
Shares Held
2.27K
Call Options Held
0
Put Options Held
0
View Full List

About Sonoma Pharmaceuticals, Inc.

SNOA Quotes by TradingView
  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8.84M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email